- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Respiratory Syncytial Viruses in Japan
Total 1274 results
-
Novartis VaccinesCompletedSwine-Origin Influenza A H1N1 VirusJapan
-
AstraZenecaCompleted
-
Genova Inc.Tokyo Shinagawa HospitalRecruiting
-
UMN Pharma Inc.Completed
-
UMN Pharma Inc.Completed
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2Japan
-
ModernaTX, Inc.CompletedCoronavirus Disease (COVID-19)Japan
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
TakedaWithdrawnSurvey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 SymptomsCoronavirus Disease (COVID-19)Japan
-
Daiichi Sankyo Co., Ltd.Completed
-
Kitasato UniversityActive, not recruiting
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
University of ShizuokaHamamatsu University; Seirei Hamamatsu General HospitalCompleted
-
Ology BioservicesBaxter Innovations GmbHCompleted
-
Ology BioservicesCompleted
-
Bristol-Myers SquibbCompleted
-
Masahiro MorikawaWhite Cross Nursing HomeCompletedInfluenza InfectionJapan
-
UMN Pharma Inc.CompletedVirus Diseases | InfluenzaJapan
-
Humanity & Health Medical Group LimitedTokyo University; Nihon University School of MedicineRecruiting
-
TakedaCompleted
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
GlaxoSmithKlineCompleted
-
Kameda Medical CenterMerck Sharp & Dohme LLC; PPD; Osaka UniversityCompletedInfluenza | Pneumococcal PneumoniaJapan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
University of ShizuokaWhite Cross Nursing Home; Seirei Hamamatsu General Hospital; Shizuoka General...Completed
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompletedCOVID-19 Lower Respiratory InfectionJapan
-
Daiichi Sankyo Co., Ltd.CompletedInfluenza, HumanTaiwan, Japan, Korea, Republic of, China
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
AstraZenecaIqvia Pty LtdCompleted
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedInfluenza and Other Novel Respiratory VirusesUnited States, Chile, United Kingdom, Spain, Argentina, Australia, Thailand, Peru, Germany, Japan, Greece, Belgium, Denmark, Estonia, Poland
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
Taiko Pharmaceutical Co., Ltd.UnknownRespiratory InfectionJapan
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
Ology BioservicesBaxter Innovations GmbHCompleted
-
TakedaTerminated
-
National Hospital Organization Minami Kyoto HospitalRecruiting
-
National Hospital Organization Minami Kyoto HospitalCompletedRehabilitation | Chronic Respiratory Failure | Exercise Endurance | Nasal High Flow TherapyJapan
-
SanofiCompleted
-
National Hospital Organization Minami Kyoto HospitalCompletedRespiratory Failure | Exercise Capacity | High-flow Nasal CannulaJapan
-
West Japan Thoracic Oncology GroupUnknown
-
National Hospital Organization Minami Kyoto HospitalRecruitingChronic Respiratory Failure | Exercise Capacity | High-flow Nasal Cannula | Optimal SpO2 ValueJapan
-
Mitsubishi Tanabe Pharma CorporationThe Research Foundation for Microbial Diseases of Osaka UniversityCompletedPertussis | Tetanus | Diphtheria | Bacterial Meningitis | PoliomyelitisJapan